| __timestamp | ADMA Biologics, Inc. | Corcept Therapeutics Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 5915545 | 26551000 |
| Thursday, January 1, 2015 | 7177633 | 50286000 |
| Friday, January 1, 2016 | 10661037 | 81321000 |
| Sunday, January 1, 2017 | 22760560 | 159201000 |
| Monday, January 1, 2018 | 16985290 | 251247000 |
| Tuesday, January 1, 2019 | 29349083 | 306486000 |
| Wednesday, January 1, 2020 | 42219783 | 353874000 |
| Friday, January 1, 2021 | 80942625 | 365978000 |
| Saturday, January 1, 2022 | 154079692 | 401858000 |
| Sunday, January 1, 2023 | 258214999 | 482375000 |
Cracking the code
In the competitive landscape of biotechnology, revenue growth is a key indicator of success. Over the past decade, Corcept Therapeutics Incorporated and ADMA Biologics, Inc. have showcased remarkable trajectories. Starting in 2014, Corcept Therapeutics reported revenues approximately four times higher than ADMA Biologics. By 2023, Corcept's revenue surged to nearly 482% of its 2014 figures, while ADMA Biologics experienced an impressive growth of over 4,260%.
Corcept Therapeutics consistently outpaced ADMA Biologics, maintaining a lead throughout the years. However, ADMA's aggressive growth strategy is evident, with its revenue increasing from a modest 6 million in 2014 to a substantial 258 million in 2023. This growth reflects a strategic pivot and successful market penetration.
As both companies continue to innovate, their revenue trajectories will be crucial for investors and stakeholders to watch.
argenx SE vs Corcept Therapeutics Incorporated: Examining Key Revenue Metrics
Teva Pharmaceutical Industries Limited vs Corcept Therapeutics Incorporated: Examining Key Revenue Metrics
Breaking Down Revenue Trends: Dr. Reddy's Laboratories Limited vs Corcept Therapeutics Incorporated
Jazz Pharmaceuticals plc and Corcept Therapeutics Incorporated: A Comprehensive Revenue Analysis
Jazz Pharmaceuticals plc vs ADMA Biologics, Inc.: Annual Revenue Growth Compared
Halozyme Therapeutics, Inc. and ADMA Biologics, Inc.: A Comprehensive Revenue Analysis
Revenue Insights: Grifols, S.A. and Corcept Therapeutics Incorporated Performance Compared
Revenue Insights: Corcept Therapeutics Incorporated and Veracyte, Inc. Performance Compared
Research and Development Expenses Breakdown: Corcept Therapeutics Incorporated vs ADMA Biologics, Inc.
Corcept Therapeutics Incorporated vs Merus N.V.: Examining Key Revenue Metrics
Corcept Therapeutics Incorporated vs Evotec SE: Annual Revenue Growth Compared
Breaking Down Revenue Trends: ADMA Biologics, Inc. vs Perrigo Company plc